Chest Journal Podcasts

Mark L. Metersky, MD, FCCP, and Scott Manker, MD, FCCP, discuss the merits of injectable corticotropin vs. corticosteroids with CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, given the exponentially higher cost of the former.

Clive Kearon, MD, PhD, and COL Lisa K. Moores, MC, USA, FCCP, join CHEST Evidence-Based Medicine Section Editor, Ian T. Nathanson, MD, FCCP, to review the important updates to the VTE Guidelines. This is the first of the topic updates to CHEST since the move to a "living guidelines" model, where topics will be updated on a rolling basis, not compiled into a single supplement containing all updates.

Courtney R. Bruce, JD, MA, and Trevor Bibler, PhD, joint CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss how their institution navigates and interprets differences in written advance directives and in-person requests from surrogate decision makers. They highlight one case study to demonstrate their process.

Borja G. Cosio, MD, and Peter Barnes, MD, Master FCCP, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss Dr. Cosio et al's study that proposes diagnostic criteria to identify patients with asthma-COPD overlap syndrome (ACOS).

Renda Soylenz Wiener, MD, MPH; Nichole T. Tanner, MD, MSCR; and editorialist David R. Baldwin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss a series of articles in this month's issue of CHEST focusing on pulmonary nodules and whether guidelines affect decisions on patient diagnosis and treatment.

Paul P. Walker, MD, and editorialist David M. Mannino, MD, FCCP, are interviewed by CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to review the research by Walker et al on heroin smokers and their risk of developing COPD at an early age.

Andrew N. Menzies-Gow, PhD, and editorialist Matthew Masoli, MD, are interviewed by CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by the British Thoracic Society Difficult Asthma Network showing that a dedicated severed asthma center is associated with improved quality of life and asthma control and a reduction in health-care use and oral steroid burden.

Joining CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, Mark V. Avdalic, MD, argues the case for, and Holly R. Middlekauff, MD, argues the cases against, painting electronic cigarettes as harmful products whose use clinicians should discourage.

Armin Ernest, MD, FCCP, and editorialist Michael J. Simoff, MD, FCCP, join guest podcast editor, Septimiu Murgu, MD, FCCP, to discsuss the new expert panel report from CHEST assessing the current state of bronchosopy training. Among topics they discuss are the role of societies and certification processes.

Hans J. Lee, MD, and Malcolm DeCamp, MD, join CHEST podcast editor D. Kyle Hogarth, MD, FCCP, to discuss the merits, pro and con, on the benefits of a small- vs. large bore catheter.

CHEST Ultrasound Corner Section Editor Seth Koenig, MD, FCCP, and Haney Mallemat, MD, are interviewed by CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP on the growth of use of ultrasound in the ICU and the resources that the CHEST organization provides to train physicians on its use.

Tina Shah, MD, MPH; Jeffrey H. Jennings, MD, and editorialist Byron Thomashow, MD, FCCP, engage in a wide-ranging discussion with CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, on the difficult issue of reducing readmissions for patients with COPD. Studies by Dr. Shah and colleagues and Dr. Jennings et al are highlighted.

Gerard J. Criner, MD, FCCP, is interviewed by CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, on the just released guidelines for the prevention of acute exacerbations of COPD, a major cause of morbidity and mortality in the United States and the world.

Rami Doukky, MD, and editorialist Lisa K. Moores, MD, FCCP, meet in conversation with CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP to discuss Dr. Doukky et al's retrospective study showing that highly sensitive cardiac troponin I assay provides a good prognostic negative predictive value; consequently, it can play a role in identifying candidates for out-of-hospital treatment of acute PE.

Steven D. Nathan, MD, FCCP, is interviewed by CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, on his commentary discussing near- and long-term trends in lung transplantation, including new criteria for donors, procedures, and novel therapies.

Bruce L. Davidson, MD, MPH, FCCP, joins CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to elaborate on his Commentary in this month's issue, outlining that direct thrombin inhibitor anticoagulants are associated with cardiac thromboses and making the case that, except for rare instances, alternatives should be prescribed.

Geoffrey B. Johnson, MD, PhD, reviews the Ahead of the Curve Commentary in this month's issue which looks to the near-future clinical uses of thoracic PET scanning. He joins CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to discuss improvements in the  technology, highlighting better resolution, ability to identify trace amounts of imaging agents, and use in chemotherapy monitoring. 

Subroto Paul, MD, FCCP, and Malcolm M. DeCamp, MD, FCCP, take time to discuss the article by Dr. Paul and colleagues in the December 2014 issue of CHEST with Podcast Editor D. Kyle Hogarth, MD, FCCP. Their study evaluated the effectiveness of robotic-assisted vs thoracoscopic lobectomy. Thus far, in the early days of its use, they found that robotic-assisted lobectomy is associated with more injury and bleeding at a higher cost. The participants discussed potential future directions for robotics in this area.

Two of the policy statement's authors, Peter J. Mazzone, MD, FCCP, and Gerard A. Silverstri, MD, FCCP, are interviewed by CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to outline the nine components needed for high quality lung cancer screening programs as identified by speciality groups of CHEST and ATS. It is hoped that this statement will guide those who set up lung cancer screening programs and will help to clarify standards for reimbursement.

Allan J. Walkey, MD, and editorialist Gregory Y. H. Lip, MD, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to discuss the research by Dr. Walkey et al showing that patients who developed new-onset atrial fibrillation during sepsis were more likely than those who did not to be at greater risk for hospitalizations for heart failure, ischemic stroke, and death. They discuss the need for follow up for these patients.